Gilead Sciences, Inc. v. Natco Pharma Limited
Petition for certiorari denied on March 9, 2015
Issue: Whether, contrary to this Court’s consistent and longstanding precedent and Congress’s intent, the double-patenting doctrine can be used to invalidate a properly issued patent before its statutory term has expired using a second, later-issuing patent whose term of exclusivity is entirely subsumed within that first patent’s term.
| Date | Proceedings and Orders (key to color coding) |
|---|
| Oct 9 2014 | Application (14A391) to extend the time to file a petition for a writ of certiorari from October 27, 2014 to November 26, 2014, submitted to The Chief Justice. |
| Oct 15 2014 | Application (14A391) granted by The Chief Justice extending the time to file until November 26, 2014. |
| Nov 26 2014 | Petition for a writ of certiorari filed. (Response due January 5, 2015) |
| Dec 22 2014 | Order extending time to file response to petition to and including February 4, 2015. |
| Dec 29 2014 | Brief amici curiae of The Pharmaceutical Research and Manufacturers of America, et al, filed. |
| Feb 4 2015 | Brief of respondents Natco Pharma Limited, et al. in opposition filed. |
| Feb 17 2015 | Reply of petitioners Gilead Sciences, Inc., et al. filed. |
| Feb 18 2015 | DISTRIBUTED for Conference of March 6, 2015. |
| Mar 9 2015 | Petition DENIED. |
